About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Fgfr1tm1Jpa
targeted mutation 1, Juha Partanen
MGI:2448986
Summary 26 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Fgfr2tm1Dor/Fgfr2+
Fgfr3tm6.1Cxd/Fgfr3tm6.1Cxd
Foxg1tm1(cre)Skm/Foxg1+
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Frs3tm1Jheb/Frs3tm1Jheb
involves: 129 MGI:6116892
cn2
Fgfr2tm1Dor/Fgfr2tm1Dor
Fgfr3tm6.1Cxd/Fgfr3tm6.1Cxd
Foxg1tm1(cre)Skm/Foxg1+
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Frs3tm1Jheb/Frs3tm1Jheb
involves: 129 MGI:6116891
cn3
Fgfr2tm1Dor/Fgfr2tm1Dor
Foxg1tm1(cre)Skm/Foxg1+
Fgfr1tm3.1Sor/Fgfr1tm1Jpa
involves: 129 MGI:6116896
cn4
Fgfr2tm1Dor/Fgfr2tm1Dor
Foxg1tm1(cre)Skm/Foxg1+
Fgfr1tm1Jpa/Fgfr1tm1Jpa
involves: 129 MGI:6116895
cn5
Fgfr2tm1Dor/Fgfr2tm1Dor
Fgfr3tm6.1Cxd/Fgfr3tm6.1Cxd
Foxg1tm1(cre)Skm/Foxg1+
Fgfr1tm6.1Jrt/Fgfr1tm1Jpa
involves: 129 MGI:6116894
cn6
Fgfr2tm1Dor/Fgfr2tm1Dor
Fgfr3tm6.1Cxd/Fgfr3tm6.1Cxd
Foxg1tm1(cre)Skm/Foxg1+
Fgfr1tm3.1Sor/Fgfr1tm1Jpa
Frs3tm1Jheb/Frs3tm1Jheb
involves: 129 MGI:6116893
cn7
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
H2az2Tg(Wnt1-cre)11Rth/H2az2+
involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J * CBA/J MGI:7339121
cn8
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Fgfr2tm1Dor/Fgfr2tm1Dor
Twist2tm1.1(cre)Dor/Twist2+
involves: 129S1/Sv * 129X1/SvJ MGI:5694227
cn9
En1tm2(cre)Wrst/En1+
Fgfr1tm1Jpa/Fgfr1tm1Jpa
involves: 129S1/Sv * 129X1/SvJ MGI:3702736
cn10
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Fgfr2tm1Dor/Fgfr2tm1Dor
Shhtm1(EGFP/cre)Cjt/Shh+
involves: 129S1/Sv * 129X1/SvJ MGI:5694226
cn11
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Fgfr2tm1Dor/Fgfr2tm1Dor
Tg(Msx2-rtTA)888Lma/0
Tg(tetO-cre)1Jaw/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 MGI:5694225
cn12
Fgfr1tm1Jpa/Fgfr1tm1.1Jpa
Fgfr2tm1Dor/Fgfr2tm1.1Dor
Twist2tm1(cre)Dor/Twist2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 MGI:3813486
cn13
Fgfr1tm1Jpa/Fgfr1+
Fgfr2tm1Dor/Fgfr2tm1.1Dor
Twist2tm1(cre)Dor/Twist2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 MGI:3813484
cn14
Fgfr1tm1Jpa/Fgfr1tm1.1Jpa
Fgfr2tm1Dor/Fgfr2+
Twist2tm1(cre)Dor/Twist2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 MGI:3813483
cn15
Fgfr1tm1Jpa/Fgfr1tm1Jpa
H2az2Tg(Wnt1-cre)11Rth/H2az2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA MGI:3702775
cn16
Fgfr1tm1Jpa/Fgfr1tm1.1Jpa
H2az2Tg(Wnt1-cre)11Rth/H2az2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * ICR MGI:3703447
cn17
Fgfr1tm1Jpa/Fgfr1tm1Jpa
H2az2Tg(Wnt1-cre)11Rth/H2az2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * ICR MGI:3703442
cn18
Fgfr1tm1Jpa/Fgfr1tm1Jpa
H2az2Tg(Wnt1-cre)11Rth/H2az2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J MGI:7339125
cn19
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Fgfr2tm1Dor/Fgfr2tm1Dor
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J MGI:3829046
cn20
Fgfr1tm1Jpa/Fgfr1+
Fgfr2tm1Dor/Fgfr2tm1Dor
Tg(Pax3-cre)1Joe/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL MGI:5438671
cn21
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Fgfr2tm1Dor/Fgfr2+
Tg(Pax3-cre)1Joe/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL MGI:5438670
cn22
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Fgfr2tm1Dor/Fgfr2tm1Dor
Tg(Pax3-cre)1Joe/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL MGI:5438672
cn23
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Fgfr2tm3.1Lni/Fgfr2tm3.1Lni
Tg(Pax3-cre)1Joe/0
involves: 129/Sv * BALB/c * C57BL/6 * FVB/N * SJL MGI:5438679
cn24
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Fgfr2tm1Dor/Fgfr2tm1Dor
Tg(Hoxb7-cre)5526Cmb/0
involves: FVB/N MGI:3525690
cn25
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Fgfr2tm1Dor/Fgfr2+
Tg(Hoxb7-cre)5526Cmb/0
involves: FVB/N MGI:3525679
cn26
Fgfr1tm1Jpa/Fgfr1+
Fgfr2tm1Dor/Fgfr2tm1Dor
Tg(Hoxb7-cre)5526Cmb/0
involves: FVB/N MGI:3525687


Genotype
MGI:6116892
cn1
Allelic
Composition
Fgfr2tm1Dor/Fgfr2+
Fgfr3tm6.1Cxd/Fgfr3tm6.1Cxd
Foxg1tm1(cre)Skm/Foxg1+
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Frs3tm1Jheb/Frs3tm1Jheb
Genetic
Background
involves: 129
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr2tm1Dor mutation (3 available); any Fgfr2 mutation (90 available)
Fgfr3tm6.1Cxd mutation (0 available); any Fgfr3 mutation (54 available)
Foxg1tm1(cre)Skm mutation (2 available); any Foxg1 mutation (29 available)
Frs3tm1Jheb mutation (0 available); any Frs3 mutation (35 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
N
• cell survival and cell division at E8.75 according to mitotic marker p-HH3 immunoreactivity

nervous system
N
• brain morphology at E12.5




Genotype
MGI:6116891
cn2
Allelic
Composition
Fgfr2tm1Dor/Fgfr2tm1Dor
Fgfr3tm6.1Cxd/Fgfr3tm6.1Cxd
Foxg1tm1(cre)Skm/Foxg1+
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Frs3tm1Jheb/Frs3tm1Jheb
Genetic
Background
involves: 129
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr2tm1Dor mutation (3 available); any Fgfr2 mutation (90 available)
Fgfr3tm6.1Cxd mutation (0 available); any Fgfr3 mutation (54 available)
Foxg1tm1(cre)Skm mutation (2 available); any Foxg1 mutation (29 available)
Frs3tm1Jheb mutation (0 available); any Frs3 mutation (35 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system




Genotype
MGI:6116896
cn3
Allelic
Composition
Fgfr2tm1Dor/Fgfr2tm1Dor
Foxg1tm1(cre)Skm/Foxg1+
Fgfr1tm3.1Sor/Fgfr1tm1Jpa
Genetic
Background
involves: 129
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr1tm3.1Sor mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr2tm1Dor mutation (3 available); any Fgfr2 mutation (90 available)
Foxg1tm1(cre)Skm mutation (2 available); any Foxg1 mutation (29 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
craniofacial

nervous system
• reduction in size across A/P and D/V axes at E12.5
• absent at E13.5 according to lack of Lhx8- and Nkx2-1-labeling of LGE region
• absent at E13.5 according to lack of Lhx8- and Nkx2-1-labeling of MGE region

vision/eye
• at E12.5




Genotype
MGI:6116895
cn4
Allelic
Composition
Fgfr2tm1Dor/Fgfr2tm1Dor
Foxg1tm1(cre)Skm/Foxg1+
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Genetic
Background
involves: 129
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr2tm1Dor mutation (3 available); any Fgfr2 mutation (90 available)
Foxg1tm1(cre)Skm mutation (2 available); any Foxg1 mutation (29 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
craniofacial

nervous system
• reduction in size across A/P and D/V axes at E12.5

vision/eye
• at E12.5




Genotype
MGI:6116894
cn5
Allelic
Composition
Fgfr2tm1Dor/Fgfr2tm1Dor
Fgfr3tm6.1Cxd/Fgfr3tm6.1Cxd
Foxg1tm1(cre)Skm/Foxg1+
Fgfr1tm6.1Jrt/Fgfr1tm1Jpa
Genetic
Background
involves: 129
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr1tm6.1Jrt mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr2tm1Dor mutation (3 available); any Fgfr2 mutation (90 available)
Fgfr3tm6.1Cxd mutation (0 available); any Fgfr3 mutation (54 available)
Foxg1tm1(cre)Skm mutation (2 available); any Foxg1 mutation (29 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
N
• brain morphology at E12.5




Genotype
MGI:6116893
cn6
Allelic
Composition
Fgfr2tm1Dor/Fgfr2tm1Dor
Fgfr3tm6.1Cxd/Fgfr3tm6.1Cxd
Foxg1tm1(cre)Skm/Foxg1+
Fgfr1tm3.1Sor/Fgfr1tm1Jpa
Frs3tm1Jheb/Frs3tm1Jheb
Genetic
Background
involves: 129
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr1tm3.1Sor mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr2tm1Dor mutation (3 available); any Fgfr2 mutation (90 available)
Fgfr3tm6.1Cxd mutation (0 available); any Fgfr3 mutation (54 available)
Foxg1tm1(cre)Skm mutation (2 available); any Foxg1 mutation (29 available)
Frs3tm1Jheb mutation (0 available); any Frs3 mutation (35 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
N
• cell division at E8.75 according to mitotic marker p-HH3 immunoreactivity
• according to TUNEL assay at E8.75

nervous system




Genotype
MGI:7339121
cn7
Allelic
Composition
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
H2az2Tg(Wnt1-cre)11Rth/H2az2+
Genetic
Background
involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J * CBA/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Gt(ROSA)26Sortm1Sor mutation (7 available); any Gt(ROSA)26Sor mutation (993 available)
H2az2Tg(Wnt1-cre)11Rth mutation (2 available); any H2az2 mutation (26 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
craniofacial
• maxillary processes are slightly reduced at E10.5
• frontonasal prominence is slightly reduced at E10.5
• cranial neural crest (CNC) cell participation in the frontonasal prominence is markedly reduced
• however, neural tube formation is normal

digestive/alimentary system
• maxillary processes are slightly reduced at E10.5

growth/size/body
• maxillary processes are slightly reduced at E10.5

skeleton
• maxillary processes are slightly reduced at E10.5




Genotype
MGI:5694227
cn8
Allelic
Composition
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Fgfr2tm1Dor/Fgfr2tm1Dor
Twist2tm1.1(cre)Dor/Twist2+
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr2tm1Dor mutation (3 available); any Fgfr2 mutation (90 available)
Twist2tm1.1(cre)Dor mutation (1 available); any Twist2 mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
• reduced cell proliferation in genital mesenchyme




Genotype
MGI:3702736
cn9
Allelic
Composition
En1tm2(cre)Wrst/En1+
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
En1tm2(cre)Wrst mutation (1 available); any En1 mutation (34 available)
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• extensive deletions are seen in the posterior midbrain
• however, no extensive deletions or alterations are seen in the basal plate of the midbrain-hindbrain region and no change in apoptosis is seen in the dorsal midbrain at E9.5
• absence of the inferior colliculus in the posterior midbrain in newborn mice
• appears disorganized
• abnormal foliation of the hemispheres
• absent in newborns and adults
• however, in adults the trochlear motoneurons are distinguishable and the oculomotor nerve is normal in both adults and E10.5 embryos
• at E10.5 the dorsal part of the trochlear nerve can not be distinguished

behavior/neurological
• impaired performance in stationary beam and rotarod assays
• adults have a wide stance




Genotype
MGI:5694226
cn10
Allelic
Composition
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Fgfr2tm1Dor/Fgfr2tm1Dor
Shhtm1(EGFP/cre)Cjt/Shh+
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr2tm1Dor mutation (3 available); any Fgfr2 mutation (90 available)
Shhtm1(EGFP/cre)Cjt mutation (1 available); any Shh mutation (48 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
N
• mice exhibit normal early growth, size and shape of genital tubercles

renal/urinary system
• abnormal maturation of urethral epithelium




Genotype
MGI:5694225
cn11
Allelic
Composition
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Fgfr2tm1Dor/Fgfr2tm1Dor
Tg(Msx2-rtTA)888Lma/0
Tg(tetO-cre)1Jaw/0
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr2tm1Dor mutation (3 available); any Fgfr2 mutation (90 available)
Tg(Msx2-rtTA)888Lma mutation (0 available)
Tg(tetO-cre)1Jaw mutation (6 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
• underdeveloped from E11.5
• deficiency in proximodistal outgrowth at E12.5
• smaller in size at E15.5 with a lack in mesenchymal patterning
• at E11.0, genital mesenchyme exhibits a reduction in cell proliferation compared with in wild-type mice
• however, apoptosis rates are normal




Genotype
MGI:3813486
cn12
Allelic
Composition
Fgfr1tm1Jpa/Fgfr1tm1.1Jpa
Fgfr2tm1Dor/Fgfr2tm1.1Dor
Twist2tm1(cre)Dor/Twist2+
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1.1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr2tm1.1Dor mutation (0 available); any Fgfr2 mutation (90 available)
Fgfr2tm1Dor mutation (3 available); any Fgfr2 mutation (90 available)
Twist2tm1(cre)Dor mutation (0 available); any Twist2 mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
digestive/alimentary system
• there is about a third reduction in the length of the small intestine at E18.5 compared to controls
• premature crypt-like structures occur in the small intestine of E18.5 embryos before the appearance of paneth cells
• proliferation of fibroblasts found in the proximal and distal small intestine mesenchyme is significantly reduced at E18.5

endocrine/exocrine glands
• premature crypt-like structures occur in the small intestine of E18.5 embryos before the appearance of paneth cells




Genotype
MGI:3813484
cn13
Allelic
Composition
Fgfr1tm1Jpa/Fgfr1+
Fgfr2tm1Dor/Fgfr2tm1.1Dor
Twist2tm1(cre)Dor/Twist2+
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr2tm1.1Dor mutation (0 available); any Fgfr2 mutation (90 available)
Fgfr2tm1Dor mutation (3 available); any Fgfr2 mutation (90 available)
Twist2tm1(cre)Dor mutation (0 available); any Twist2 mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
digestive/alimentary system
• there is about a 15% reduction in the length of the small intestine at E18.5 compared to controls




Genotype
MGI:3813483
cn14
Allelic
Composition
Fgfr1tm1Jpa/Fgfr1tm1.1Jpa
Fgfr2tm1Dor/Fgfr2+
Twist2tm1(cre)Dor/Twist2+
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1.1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr2tm1Dor mutation (3 available); any Fgfr2 mutation (90 available)
Twist2tm1(cre)Dor mutation (0 available); any Twist2 mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
digestive/alimentary system
• there is about a 15% reduction in the length of the small intestine at E18.5 compared to controls




Genotype
MGI:3702775
cn15
Allelic
Composition
Fgfr1tm1Jpa/Fgfr1tm1Jpa
H2az2Tg(Wnt1-cre)11Rth/H2az2+
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
H2az2Tg(Wnt1-cre)11Rth mutation (2 available); any H2az2 mutation (26 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging

nervous system
• dorsal cerebellum development is abnormal
• inferior colliculus is deleted in the posterior midbrain
• the vermis is present but severely malformed




Genotype
MGI:3703447
cn16
Allelic
Composition
Fgfr1tm1Jpa/Fgfr1tm1.1Jpa
H2az2Tg(Wnt1-cre)11Rth/H2az2+
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * ICR
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1.1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
H2az2Tg(Wnt1-cre)11Rth mutation (2 available); any H2az2 mutation (26 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
craniofacial
N
• at E9.5, no defects are seen in the early development of the second branchial arch unlike mice homozygous for Fgfr1tm2Jrt
• no enhancement in later craniofacial phenotypes relative to mice homozygous for Fgfr1tm1Jrt that carry the Tg(Wnt1-cre)11Rth transgene

digestive/alimentary system

skeleton
• no enhancement in later craniofacial phenotypes relative to mice homozygous for Fgfr1tm1Jrt that carry the Tg(Wnt1-cre)11Rth transgene

growth/size/body




Genotype
MGI:3703442
cn17
Allelic
Composition
Fgfr1tm1Jpa/Fgfr1tm1Jpa
H2az2Tg(Wnt1-cre)11Rth/H2az2+
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * ICR
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
H2az2Tg(Wnt1-cre)11Rth mutation (2 available); any H2az2 mutation (26 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
craniofacial
N
• at E9.5, no defects are seen in the early development of the second branchial arch unlike mice homozygous for Fgfr1tm2Jrt
• also, the malleus, incus, stapes, styloid process, tympanic ring, alisphenoid and squamosum are normal
• lesser horn points laterally
• in newborns

digestive/alimentary system
• in newborns

skeleton
• lesser horn points laterally

growth/size/body
• in newborns




Genotype
MGI:7339125
cn18
Allelic
Composition
Fgfr1tm1Jpa/Fgfr1tm1Jpa
H2az2Tg(Wnt1-cre)11Rth/H2az2+
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
H2az2Tg(Wnt1-cre)11Rth mutation (2 available); any H2az2 mutation (26 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
craniofacial
• embryos exhibit severe tooth bud defects
• development of medial nasal processes is impaired
• cell proliferation is delayed in the mesenchymal compartment of palate shelves; BrdU incorporation assays showed reduced cell proliferation at E12.5-13.5 but enhanced proliferation at E14.5
• immunostaining of coronal sections of E14.5 embryos with anti-phosphorylated Smad1/5/8 showed increased BMP signaling especially in the anterior part of palate shelves
• cell proliferation is delayed in both the epithelial and mesenchymal compartments of palate shelves; BrdU incorporation assays showed reduced cell proliferation at E12.5-13.5 but enhanced proliferation at E14.5
• at E14.5, palatal shelves are widely separated allowing direct view of the presphenoid bone
• ex vivo, dissected E13.5 palate shelves placed in proximal apposition do fuse after 2 days in culture but the gap between the two shelves is not fully filled by mesenchymal cells and a fraction of midline epithelial seam is still present while expression of epithelial cytokeratins is not completely eliminated in the medial edge epithelium (MEE), unlike in control palate shelves
• degeneration of the MEE is compromised, as shown by less defused E-cadherin staining and a lower number of TUNEL+ apoptotic cells in MEE cells at E14.5 and reduced expression of Tgfb3 at E13.5
• palate shelves appear smaller at E13.5
• complete cleft lip observed at E14.5 and P0
• complete cleft primary palate observed at E14.5 and P0
• partially formed palate rugae observed at P0
• complete secondary palate observed at E14.5 and P0
• palate shelves continue to grow downward at both anterior and posterior positions at E14.5 and fail to elevate and complete fusion even at E15.5
• tongue position is heightened at E14.5

digestive/alimentary system
• cell proliferation is delayed in the mesenchymal compartment of palate shelves; BrdU incorporation assays showed reduced cell proliferation at E12.5-13.5 but enhanced proliferation at E14.5
• immunostaining of coronal sections of E14.5 embryos with anti-phosphorylated Smad1/5/8 showed increased BMP signaling especially in the anterior part of palate shelves
• cell proliferation is delayed in both the epithelial and mesenchymal compartments of palate shelves; BrdU incorporation assays showed reduced cell proliferation at E12.5-13.5 but enhanced proliferation at E14.5
• at E14.5, palatal shelves are widely separated allowing direct view of the presphenoid bone
• ex vivo, dissected E13.5 palate shelves placed in proximal apposition do fuse after 2 days in culture but the gap between the two shelves is not fully filled by mesenchymal cells and a fraction of midline epithelial seam is still present while expression of epithelial cytokeratins is not completely eliminated in the medial edge epithelium (MEE), unlike in control palate shelves
• degeneration of the MEE is compromised, as shown by less defused E-cadherin staining and a lower number of TUNEL+ apoptotic cells in MEE cells at E14.5 and reduced expression of Tgfb3 at E13.5
• palate shelves appear smaller at E13.5
• complete cleft primary palate observed at E14.5 and P0
• partially formed palate rugae observed at P0
• complete secondary palate observed at E14.5 and P0
• palate shelves continue to grow downward at both anterior and posterior positions at E14.5 and fail to elevate and complete fusion even at E15.5
• tongue position is heightened at E14.5

growth/size/body
• embryos exhibit severe tooth bud defects
• cell proliferation is delayed in the mesenchymal compartment of palate shelves; BrdU incorporation assays showed reduced cell proliferation at E12.5-13.5 but enhanced proliferation at E14.5
• immunostaining of coronal sections of E14.5 embryos with anti-phosphorylated Smad1/5/8 showed increased BMP signaling especially in the anterior part of palate shelves
• cell proliferation is delayed in both the epithelial and mesenchymal compartments of palate shelves; BrdU incorporation assays showed reduced cell proliferation at E12.5-13.5 but enhanced proliferation at E14.5
• at E14.5, palatal shelves are widely separated allowing direct view of the presphenoid bone
• ex vivo, dissected E13.5 palate shelves placed in proximal apposition do fuse after 2 days in culture but the gap between the two shelves is not fully filled by mesenchymal cells and a fraction of midline epithelial seam is still present while expression of epithelial cytokeratins is not completely eliminated in the medial edge epithelium (MEE), unlike in control palate shelves
• degeneration of the MEE is compromised, as shown by less defused E-cadherin staining and a lower number of TUNEL+ apoptotic cells in MEE cells at E14.5 and reduced expression of Tgfb3 at E13.5
• palate shelves appear smaller at E13.5
• complete cleft lip observed at E14.5 and P0
• complete cleft primary palate observed at E14.5 and P0
• partially formed palate rugae observed at P0
• complete secondary palate observed at E14.5 and P0
• palate shelves continue to grow downward at both anterior and posterior positions at E14.5 and fail to elevate and complete fusion even at E15.5
• tongue position is heightened at E14.5

skeleton
• embryos exhibit severe tooth bud defects




Genotype
MGI:3829046
cn19
Allelic
Composition
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Fgfr2tm1Dor/Fgfr2tm1Dor
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr2tm1Dor mutation (3 available); any Fgfr2 mutation (90 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
craniofacial
• severe facial clefting is seen

cardiovascular system
N
• despite ubiquitous expression of these genes in the anterior of the embryo, no defects in outflow tract development are seen

growth/size/body
• severe facial clefting is seen




Genotype
MGI:5438671
cn20
Allelic
Composition
Fgfr1tm1Jpa/Fgfr1+
Fgfr2tm1Dor/Fgfr2tm1Dor
Tg(Pax3-cre)1Joe/0
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr2tm1Dor mutation (3 available); any Fgfr2 mutation (90 available)
Tg(Pax3-cre)1Joe mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
renal/urinary system
N
• mice exhibit normal-appearing kidneys after birth
• kidneys exhibit normal cortical and medullary structures at E16.5 and remain normal throughout embryonic development




Genotype
MGI:5438670
cn21
Allelic
Composition
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Fgfr2tm1Dor/Fgfr2+
Tg(Pax3-cre)1Joe/0
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr2tm1Dor mutation (3 available); any Fgfr2 mutation (90 available)
Tg(Pax3-cre)1Joe mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
renal/urinary system
N
• mice exhibit normal-appearing kidneys after birth
• kidneys exhibit normal cortical and medullary structures at E16.5 and remain normal throughout embryonic development




Genotype
MGI:5438672
cn22
Allelic
Composition
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Fgfr2tm1Dor/Fgfr2tm1Dor
Tg(Pax3-cre)1Joe/0
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr2tm1Dor mutation (3 available); any Fgfr2 mutation (90 available)
Tg(Pax3-cre)1Joe mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
renal/urinary system
• at E10.5, many apoptotic (TUNEL+) cells are present in the very loose mesenchyme adjacent to the ureteric bud, unlike in controls
• abnormally high rates of apoptosis are detected in mesenchyme dorsal to the initial ureteric bud at E10.5 and then in the rudimentary ureteric bud and Wolffian duct at E11.5
• at E10.5, mice exhibit local areas of hypoproliferation (decreased BrdU uptake) in mesenchyme dorsal to the ureteric bud (where metanephric mesenchyme should be present)
• at E10.5, mice exhibit no histologically recognizable condensing metanephric mesenchyme within the loose mesenchyme, unlike controls
• by E11.5, no definitive metanephric mesenchyme is seen around the unbranched ureteric buds, unlike in controls
• mice exhibit total renal aplasia
• however, mice develop bladders and structures originating from intermediate mesoderm including ovaries, testes, Mullerian ducts, and ductus deferens
• mice occasionally develop two initial ureteric buds from the Wolffian duct, unlike controls
• failure of uteretic buds to branch by E11.5
• by E11.5, ureteric buds fail to elongate or branch
• mice occasionally develop an ectopic ureteric bud
• a smaller ureteric bud is usually observed at E10.5 and E11.0

cellular
• at E10.5, many apoptotic (TUNEL+) cells are present in the very loose mesenchyme adjacent to the ureteric bud, unlike in controls
• abnormally high rates of apoptosis are detected in mesenchyme dorsal to the initial ureteric bud at E10.5 and then in the rudimentary ureteric bud and Wolffian duct at E11.5
• at E10.5, mice exhibit local areas of hypoproliferation (decreased BrdU uptake) in mesenchyme dorsal to the ureteric bud (where metanephric mesenchyme should be present)

embryo
• at E10.5, many apoptotic (TUNEL+) cells are present in the very loose mesenchyme adjacent to the ureteric bud, unlike in controls




Genotype
MGI:5438679
cn23
Allelic
Composition
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Fgfr2tm3.1Lni/Fgfr2tm3.1Lni
Tg(Pax3-cre)1Joe/0
Genetic
Background
involves: 129/Sv * BALB/c * C57BL/6 * FVB/N * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr2tm3.1Lni mutation (0 available); any Fgfr2 mutation (90 available)
Tg(Pax3-cre)1Joe mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
renal/urinary system
• at E10.5, mice exhibit a severe reduction in the size of condensed metanephric mesenchyme relative to controls, as shown by H&E staining
• still images of 3D reconstructions show a 70% reduction in metanephric mesenchyme volume at E10.5
• at E11.5, the metanephric mesenchyme remains small and less condensed, unlike in controls
• by E12.5, high levels of apoptosis are noted throughout the remnant metanephric mesenchyme, as revealed by TUNEL staining
• however, no obvious differences in mesenchymal proliferation or apoptosis are noted at E10.5 and E11.5 relative to controls
• no apparent kidney tissues are observed at E13.5 and E18.5
• at E11.5, ureteric buds remain unbranched, unlike in controls
• at E11.5, none of the ureteric buds elongate into the metanephric mesenchyme, unlike in controls
• a subset of mice develop an anteriorly displaced secondary ureteric bud, unlike in controls
• at E11.5, ureteric buds are small and unbranched, unlike in controls

cellular
• by E12.5, high levels of apoptosis are noted throughout the remnant metanephric mesenchyme, as revealed by TUNEL staining
• however, no obvious differences in mesenchymal proliferation or apoptosis are noted at E10.5 and E11.5 relative to controls

embryo
• by E12.5, high levels of apoptosis are noted throughout the remnant metanephric mesenchyme, as revealed by TUNEL staining
• however, no obvious differences in mesenchymal proliferation or apoptosis are noted at E10.5 and E11.5 relative to controls




Genotype
MGI:3525690
cn24
Allelic
Composition
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Fgfr2tm1Dor/Fgfr2tm1Dor
Tg(Hoxb7-cre)5526Cmb/0
Genetic
Background
involves: FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr2tm1Dor mutation (3 available); any Fgfr2 mutation (90 available)
Tg(Hoxb7-cre)5526Cmb mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
renal/urinary system
• reduced numbers of glomeruli in both embryonic and adult kidneys
• some adult mutants had hydronephrosis occurring unilaterally or bilaterally
• E13.5 and E16.5 kidneys were smaller than controls
• many adult mutants had small, abnormally shaped kidneys
• E11.5 ureteric bud explants had abnormally thin, long ureteric stalks and fewer peripheral tips, with a range in phenotype severity
• decrease in the mean number of ureteric bud tips on the surface of E16.5 kidneys
• range of ureteric bud defects at E16.5, including extremely small kidneys with large areas devoid of ureteric tissue




Genotype
MGI:3525679
cn25
Allelic
Composition
Fgfr1tm1Jpa/Fgfr1tm1Jpa
Fgfr2tm1Dor/Fgfr2+
Tg(Hoxb7-cre)5526Cmb/0
Genetic
Background
involves: FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr2tm1Dor mutation (3 available); any Fgfr2 mutation (90 available)
Tg(Hoxb7-cre)5526Cmb mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
renal/urinary system
N
• normal kidneys and no apparent renal abnormalities




Genotype
MGI:3525687
cn26
Allelic
Composition
Fgfr1tm1Jpa/Fgfr1+
Fgfr2tm1Dor/Fgfr2tm1Dor
Tg(Hoxb7-cre)5526Cmb/0
Genetic
Background
involves: FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr1tm1Jpa mutation (0 available); any Fgfr1 mutation (223 available)
Fgfr2tm1Dor mutation (3 available); any Fgfr2 mutation (90 available)
Tg(Hoxb7-cre)5526Cmb mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
renal/urinary system
• 22% and 24% fewer glomeruli in E11.5 explants and adult kidneys, respectively
• defects in cortical stromal mesenchyme patterning, showing aberrantly thickened stroma in subcapsular regions in E13.5 kidneys and regions of massive subcapsular apoptosis in stroma
• absent intercalated stripes of stromal cells in E13.5 kidneys
• 20% of adult mutants had hydronephrosis occurring unilaterally or bilaterally
• E13.5 and E16.5 kidneys were smaller than controls
• 80% of adult mutants had small, abnormally shaped kidneys
• range of ureteric bud defects at E16.5, including extremely small kidneys with large areas devoid of ureteric tissue
• increased apoptotic nuclei in ureteric buds (2-3 apoptotic nuclei compared to none or just one in controls)
• decreased rates of proliferation in ureteric bud tips compared with controls
• E11.5 ureteric bud explants exhibited aberrant branching and had abnormally thin, long ureteric stalks and fewer peripheral tips, with a range in phenotype severity
• decrease in the mean number of ureteric bud tips on the surface of E16.5 kidneys (89.5 versus 271 in control)





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory